DYN - Dyne Therapeutics  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DYN is currently covered by 10 analysts with an average price target of $34.72. This is a potential upside of $24.67 (245.47%) from yesterday's end of day stock price of $10.05.

Dyne Therapeutics 's activity chart (see below) currently has 26 price targets and 65 ratings on display. The stock rating distribution of DYN is 95.74% BUY and 4.26% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 52.76% with an average time for these price targets to be met of 240.3 days.

Highest price target for DYN is $66, Lowest price target is $17, average price target is $43.7.

Most recent stock forecast was given by DEBJIT CHATTOPADHYAY from GUGGENHEIM on 18-Jun-2025. First documented stock forecast 12-Oct-2020.

Split History since 2000:

5/25/10 1 for 5

8/22/00 2 for 1

2/1/00 69 for 100

Currently out of the existing stock ratings of DYN, 45 are a BUY (95.74%), 2 are a HOLD (4.26%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$50

$39.68 (384.50%)

9 days ago
(18-Jun-2025)

2/4 (50%)

$39.22 (363.82%)

302

Buy

$50

$39.68 (384.50%)

$50

10 days ago
(17-Jun-2025)

6/11 (54.55%)

$39.14 (360.41%)

197

Buy

$37

$26.68 (258.53%)

$56

16 days ago
(11-Jun-2025)

3/5 (60%)

$22.43 (153.95%)

286

Buy

$34

$23.68 (229.46%)

$55

25 days ago
(02-Jun-2025)

5/7 (71.43%)

$21.3 (167.72%)

216

Buy

$38

$27.68 (268.22%)

$46

1 months 18 days ago
(09-May-2025)

2/10 (20%)

$26.59 (233.04%)

104

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is DYN (Dyne Therapeutics ) average time for price targets to be met?

On average it took 240.3 days on average for the stock forecasts to be realized with a an average price target met ratio 52.76

Which analyst has the current highest performing score on DYN (Dyne Therapeutics ) with a proven track record?

FRANCOIS BRISEBOIS

Which analyst has the most public recommendations on DYN (Dyne Therapeutics )?

Francois Brisebois works at OPPENHEIMER and has 3 price targets and 2 ratings on DYN

Which analyst is the currently most bullish on DYN (Dyne Therapeutics )?

Paul Matteis with highest potential upside - $55.68

Which analyst is the currently most reserved on DYN (Dyne Therapeutics )?

Tessa Romero with lowest potential downside - $6.68

Dyne Therapeutics  in the News

Dyne Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights

– FDA (CDER) Type C meeting held in May 2025 for DYNE-101 in DM1 and Dyne plans to provide a regulatory update following receipt of meeting minutes – – Registrational Expansion Cohort of ACHIEVE Trial of DYNE-101 in DM1 initiated to support potential submission for U.S. Accelerated Approval in H1 2026 – – Registrational Expansion...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?